Sanderling Ventures
VC
INVESTOR TYPE
Active
STATUS
8
PROFESSIONALS
155
INVESTMENTS
18
PORTFOLIO
58
EXITS
Description
Sanderling Ventures is a venture capital firm that was founded in 1979. The firm prefers to invest in the biotechnology, life sciences, therapeutics and pharmaceuticals, drug delivery, medical devices and instrumentation, diagnostics, medical informatics, healthcare information technology and health care services sectors.
Website
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
1979
Primary Investor Type
Venture Capital
Other Investor Types
Limited Partner
Primary Office
- 400 South El Camino Real
- Suite 1200
- San Mateo, CA 94402
- United States
+1 (650) 000-0000
Sanderling Ventures Investments (155)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| ViaCyte | 29-Nov-2018 | Later Stage VC | 0000 | Drug Discovery | Generating Revenue | |
| 00000000000 | 15-Dec-2017 | 00000 00000 | 0000 | Therapeutic Devices | Clinical Trials - Phase 2 | 0000000 00000 00.0 |
| 0000000000 000000 | 23-Aug-2017 | 0000 00000 | 000 | Biotechnology | Clinical Trials - Phase 1 | |
| 0000000000 | 27-Jul-2017 | 00000 00000 | 0000 | Medical Supplies | Startup | 00000 0000000000 00.0 |
| 0000000000 | 10-May-2017 | 0000 00000 | Medical Supplies | Startup | 000000 00000000000 00.0 | |
| 000000000 | 16-Nov-2016 | 00000 00000 | 0000 | Therapeutic Devices | Generating Revenue | 00000 0000000000 00.0 |
| 00000 0000000 | 25-Jul-2016 | 00000 00000 | 0000 | Surgical Devices | Generating Revenue | 0000000 00000 00.0 |
| 000000000 | 20-May-2016 | 00000 00000 | 00.000 | Pharmaceuticals | Clinical Trials - Phase 2 | 00000 000000 00.0 |
| DalCor Pharmaceuticals | 13-May-2016 | Early Stage VC | 0000 | Biotechnology | Clinical Trials - Phase 3 | 000000 000000 00.0 |
| DalCor Pharmaceuticals | 01-Jan-2015 | Early Stage VC | 0000 | Biotechnology | Clinical Trials - Phase 3 | 000000 000000 00.0 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Sanderling Ventures’s full profile, request a free trial.
Sanderling Ventures Exits (58)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Altor BioScience | 01-Aug-2017 | Merger/Acquisition | 000 | Completed | |
| 00000000 | 01-Jun-2017 | 0000000000: 000000 | Completed |
|
|
| 00000 0000000 | 23-Mar-2017 | 000000000000000000 | Completed |
|
|
| 000000 00000000 | 08-Dec-2016 | 000000000000000000 | Completed |
|
|
| 00000000 | 01-Dec-2016 | 000 00 00000000 | Completed |
|
|
| 000000 00000000 | 07-Oct-2016 | 0000000000: 000000 | Completed |
|
|
| 0000000000 | 10-Jun-2016 | 000000000000000000 | 00000 | Completed |
|
| 000000000 | 31-Oct-2015 | 000000000000000000 | 0000 | Completed |
|
| Chimerix | 01-Apr-2015 | Secondary Transaction - Open Market | Completed |
|
|
| Tomophase | 18-Apr-2014 | Merger/Acquisition | Completed |
|
Sanderling Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is reserved for PitchBook Platform accredited users. To explore Sanderling Ventures‘s full profile, request access.
Request full access to PitchBookSanderling Ventures Team (19)
7 Former Team Members
You’re viewing 5 of 19 team members. Get the full list »Sanderling Ventures Co-Investors (26)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| CTI Life Sciences Fund | 2 | 0 | |
| Fonds de solidarité FTQ | 0 | 0 | |
| Revelation Partners | 0 | 0 | 0 |
| Bain Capital | 0 | 0 | |
| Piper Jaffray | 0 | 0 | 0 |